Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06507189 · ClinicalTrials.gov registry record · NA

Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)

A NA study of Sarcopenia, sponsored by Florida Institute for Human and Machine Cognition.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT06507189: Recruiting NA study of Sarcopenia, sponsored by Florida Institute for Human and Machine Cognition.

NCT06507189 is a NA study of Sarcopenia that is actively recruiting participants, run by Florida Institute for Human and Machine Cognition. The registered enrollment target is 250 participants, above the 74-participant average among 41 other Sarcopenia trials with a reported enrollment target (238% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06507189, a NA study of Sarcopenia, is actively recruiting participants, sponsored by Florida Institute for Human and Machine Cognition.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

Aging-related functional declines are thought to be caused by hallmark biological processes that ultimately manifest in physical, mental, and metabolic impairments that compromise healthspan and quality of life. Exercise is a multipotent treatment with promise to mitigate most aging hallmarks, but there is substantial variability in exercisƒe responsiveness. Combining endurance and resistance training in alignment with public health guidelines will be used to better understand variable exercise responsiveness in older adults with the ultimate goal of improving each older adult's capacity to attain the many health benefits of exercise.

Primary Outcome

A primary outcome of this investigation is cardiorespiratory fitness (CRF). The CRF is the amount of oxygen (ml/kg) that is used during exercise and how efficient you are using that oxygen. The exercise used to measure oxygen uptake is a stationary bicycle with increasing intensity until you are able to maintain pace. Your expired air is collected with a mask or mouthpiece and analyzed with an oxygen and carbon dioxide sensor.

Conditions Studied

Interventions

  • OTHER Combined endurance and resistance training

Study Locations (2)

Florida

  • Florida Institute for Human and Machine Cognition - Pensacola

Oklahoma

  • Oklahoma Medical Research Foundation - Oklahoma City

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-01-27
Est. Completion 2029-08-31
Phase NA

What NCT06507189 shows while recruiting

NCT06507189 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 74-participant average among 41 other Sarcopenia trials with a reported enrollment target (238% higher).

The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 1 intervention - of which Combined endurance and resistance training is the first listed.

NCT06507189 reports a single indexed study location in Florida, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT06507189 about?

NCT06507189 is a clinical study titled "Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)". Aging-related functional declines are thought to be caused by hallmark biological processes that ultimately manifest in physical, mental, and metabolic impairments that compromise healthspan and quality of life. Exercise is a multipotent treatment with promise to mitigate most aging hallmarks, but t...

What is the current status of trial NCT06507189?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-01-27. Estimated completion is 2029-08-31.

What conditions does trial NCT06507189 study?

This clinical trial studies the following conditions: Sarcopenia.

What interventions are being tested in trial NCT06507189?

The interventions under investigation include: Combined endurance and resistance training (OTHER).

Who is sponsoring clinical trial NCT06507189?

This trial is sponsored by Florida Institute for Human and Machine Cognition, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06507189 being conducted?

This trial has 2 study locations across Florida, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06507189's enrollment target sits among peer trials

250 2nd of 41 higher than 39 of 41 other Sarcopenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sarcopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06507189, the US trial registry maintained by the National Library of Medicine. NCT06507189 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.